Jeremy Sugarman
Johns Hopkins University
413 Papers
2.6K Citations
Jeremy Sugarman is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Informed consent & Medicine. The author has an hindex of 59, co-authored 393 publications. Previous affiliations of Jeremy Sugarman include Durham University & University of Melbourne.
Chat about Author
Papers
Consulting communities when patients cannot consent: a multicenter study of community consultation for research in emergency settings.
Neal W. Dickert,Victoria A. Mah,Michellle H. Biros,Deneil Harney,Robert Silbergleit,Jeremy Sugarman,Emir Veledar,Kevin P. Weinfurt,David W. Wright,Rebecca D. Pentz +9 more
TL;DR: Interactive community consultation methods were associated with increased acceptance of exception from informed consent and greater overall recall of study information but lower recall of risks, and have important implications for institutional review board and investigators conducting exception frominformed consent research.
Ethics in population-based genetic research.
Matthew DeCamp,Jeremy Sugarman +1 more
TL;DR: This article reviews the growing literature on genetics research and ethics to describe some of the fundamental ethical issues in population-based genetics research, including research design, recruitment and informed consent, and dealing with research results.
Evidence-Based Strategies for Shortening Informed Consent Forms in Clinical Research
Amy Corneli,Emily Namey,Monique P. Mueller,Jenae Tharaldson,Steve Sortijas,Thomas Grey,Jeremy Sugarman +6 more
TL;DR: A modified Delphi process with semistructured interviews and online surveys was used to build consensus among six groups of key stakeholders on advancing the use of shorter ICFs in clinical research.
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic.
TL;DR: Offlabel prescribing is the least favorable way to use unproven medications for COVID-19, provides the least regulatory oversight, and the least opportunity to learn from their administration.
New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research
Insoo Hyun,Olle Lindvall,Lars Ährlund-Richter,Elena Cattaneo,Marina Cavazzana-Calvo,Giulio Cossu,Michele De Luca,Ira J. Fox,Claude Gerstle,Robert A. Goldstein,Göran Hermerén,Katherine A. High,Hyun Ok Kim,Hin-Peng Lee,Ephrat Levy-Lahad,Lingsong Li,Bernard Lo,Daniel Robert Marshak,Angela McNab,Megan Munsie,Hiromitsu Nakauchi,Mahendra S. Rao,Heather M. Rooke,Carlos Simon Valles,Alok Srivastava,Jeremy Sugarman,Patrick L. Taylor,Anna Veiga,Adrianne L. Wong,Laurie Zoloth,George Q. Daley +30 more
TL;DR: The International Society for Stem Cell Research (ISSCR) task force that developed new Guidelines for the Clinical Translation of Stem Cells discusses core principles that should guide the responsible transition of basic stem cell research into appropriate clinical applications as discussed by the authors.